FDA aims to speed up biosimilar development and lower drug costs
In a new draft guidance, the FDA proposes major updates to simplify biosimilarity studies and reduce unnecessary clinical testing.
In a new draft guidance, the FDA proposes major updates to simplify biosimilarity studies and reduce unnecessary clinical testing.
The enhanced facility will be among those that will manufacture for orforglipron, Lilly’s first oral, small-molecule GLP-1 receptor agonist.
SHARx operates on a transparent pricing model—charging a simple subscription fee.
Walmart will serve as the first in-store pickup pharmacy for LillyDirect’s self-pay single-dose vials.
Study found being vaccinated against shingles decreased the risk of heart disease, dementia and death in people age 50 and older.
Amazon Pharmacy increases Same-Day Delivery to nearly 200 towns in greater Chicago, while One Medical adds telehealth service for children and specialized menopause care.
Evernorth Health Services has launched a rebate-free pharmacy benefit model with upfront discounts and real-time price comparisons.
More than 4,000 CVS Pharmacy locations across the United States now feature secure medication disposal kiosks.
Generic pharmaceutical trade group steps in to protect patient access to affordable generic drugs.
Kroger Health, with the support of the Cardinal Health Foundation, has hosted drug take back events across the U.S. since 2018.
The event gives community members the opportunity to remove potentially dangerous expired, unused, and unwanted prescription drugs from their home.
The health tech company adds more than 1,700 Albertsons Cos. pharmacies to its partnership base of over 37,000 locations.
Community Access National Network (CANN) urges lawmakers to prioritize patients over profits in 340B reforms.
A Case Western study indicates the shingles vaccine might provide broader health benefits.
Compounding pharmacies are evolving from stopgap providers during drug shortages to strategic partners in modern, personalized health care.
There are many headwinds for the industry, starting with reimbursement pressure, but also extensive opportunities for collectively modernizing approaches to elevate the role of the pharmacist.